Valeant (VRX) Declines as the Feds Start an Investigation

By |October 16th, 2015|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)
Valeant Pharmaceuticals had a rough time in the market yesterday and is continuing declines today. Unfortunately for VRX and its investors, Federal investigators have opened a case looking into how the company prices its treatments; causing massive declines in the stock. Today, we’ll talk about the investigation, how the […]